Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPLUNG.00409.2004PMID 15608146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Phosphodiesterase Type 5 by the Activator of Nitric Oxide–Sensitive Guanylyl Cyclase BAY 41-2272

  2004cited by this paper
• Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

  2004cited by this paper
• Soluble Guanylate Cyclase Activator Reverses Acute Pulmonary Hypertension and Augments the Pulmonary Vasodilator Response to Inhaled Nitric Oxide in Awake Lambs

  2004cited by this paper
• Interaction between Inhaled Nitric Oxide and Intravenous Sildenafil in a Porcine Model of Meconium Aspiration Syndrome

  2004cited by this paper
• Cardiorenal and Humoral Properties of a Novel Direct Soluble Guanylate Cyclase Stimulator BAY 41-2272 in Experimental Congestive Heart Failure

  2003cited by this paper
• Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

  2003cited by this paper
• Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

  2003cited by this paper
• Regulation of Nitric Oxide‐Sensitive Guanylyl Cyclase

  2003influential reference
• NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

  2002cited by this paper
• Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.

  2002cited by this paper
• NO-independent stimulators of soluble guanylate cyclase.

  2001cited by this paper
• NO‐Independent Stimulators of Soluble Guanylate Cyclase.

  2001cited by this paper
• Effects of catecholamines on the pulmonary circulation in the ovine fetus.

  2001cited by this paper
• NO-independent regulatory site on soluble guanylate cyclase

  2001influential reference
• Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs

  2001cited by this paper
• cGMP signalling beyond nitric oxide.

  2001cited by this paper
• Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary Hypertension

  2000cited by this paper
• Prolonged Infusions of Estradiol Dilate the Ovine Fetal Pulmonary Circulation

  2000cited by this paper
• Adenosine and ATP CauseNitric Oxide-Dependent PulmonaryVasodilation in Fetal Lambs

  2000cited by this paper
• Soluble guanylyl cyclase: structure and regulation.

  1999cited by this paper
• In Vivo Evidence for a Myogenic Response in the Fetal Pulmonary Circulation

  1999cited by this paper
• Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension.

  1998cited by this paper
• Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus.

  1998cited by this paper
• Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension.

  1997cited by this paper
• Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

  1997cited by this paper
• Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus.

  1997cited by this paper
• Endothelin blockade augments pulmonary vasodilation in the ovine fetus.

  1996cited by this paper
• Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.

  1995cited by this paper
• Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation.

  1995cited by this paper
• Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia.

  1995cited by this paper
• Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation.

  1994cited by this paper
• Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.

  1993cited by this paper
• Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

  1992cited by this paper
• Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

  1992cited by this paper
• Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation.

  1992cited by this paper
• Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus.

  1992influential reference
• Role of ATP-sensitive potassium channels in ovine fetal pulmonary vascular tone.

  1992cited by this paper
• Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries.

  1992cited by this paper
• Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro.

  1991cited by this paper
• Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions.

  1991influential reference
• Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth.

  1990influential reference
• Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation.

  1989cited by this paper
• Effects of Birth-Related Events on Central Blood Flow Patterns

  1987cited by this paper
• Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tension.

  1986cited by this paper
• Adaptation of Fetal Pulmonary Blood Flow to Local Infusion of Tolazoline

  1985cited by this paper
• Gestational Changes in Pulmonary Vascular Responses in Fetal Lambs in Utero

  1976cited by this paper
• The vascular resistance of the foetal and newly ventilated lung of the lamb

  1964cited by this paper
• Changes in the lungs of the new‐born lamb

  1953cited by this paper

• Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension.

  2026cites this paper
• New Therapeutic Targets in Neonatal Pulmonary Hypertension

  2022cites this paper
• Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide

  2022cites this paper
• Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator.

  2021cites this paper
• Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs

  2020cites this paper
• Milrinone Use in Persistent Pulmonary Hypertension of the Newborn.

  2020cites this paper
• Therapies that enhance pulmonary vascular NO-signaling in the neonate.

  2019cites this paper
• Physiologie du fœtus et du nouveau-né – adaptation à la vie extra-utérine

  2018cites this paper
• Sodium nitrite augments lung S-nitrosylation and reverses chronic hypoxic pulmonary hypertension in juvenile rats.

  2018cites this paper
• Recomendaciones del VI Consenso Clínico de SIBEN para la Hipertensión Pulmonar Persistente del Recién Nacido

  2017cites this paper
• Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology.

  2017cites this paper
• Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?

  2016cites this paper
• Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia.

  2016cites this paper
• Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn

  2015cites this paper
• Update on PPHN: mechanisms and treatment.

  2014cites this paper
• Endothelial nitric oxide synthase‐enhancing G‐protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin‐1‐dependent and endothelin‐1‐independent pathways in a monocrotaline model

  2014cites this paper
• Fetal Lamb Effects of Phosphodiesterase 5 Inhibitor on Pulmonary Vascular Reactivity in the

  2013cites this paper
• Smooth muscle cell proliferation and endothelin pathway in pulmonary arterial hypertension : comparative effects of current and putative therapeutic agents

  2013cites this paper
• Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment.

  2013cites this paper
• The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia

  2013cites this paper
• Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications

  2013cites this paper
• Stimulators of soluble guanylyl cyclase: future clinical indications.

  2013cites this paper
• Disease Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary

  2013cites this paper
• Soluble guanylate cyclase stimulators in pulmonary hypertension.

  2013cites this paper
• Physiology of transition from intrauterine to extrauterine life.

  2012cites this paper
• The pulmonary circulation in neonatal respiratory failure.

  2012cites this paper
• Stimulators and Activators of Soluble Guanylate Cyclase: Review and Potential Therapeutic Indications

  2012cites this paper
• Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.

  2011cites this paper
• Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.

  2010cites this paper
• Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies

  2010cites this paper
• Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide.

  2010influential citation
• Soluble Guanylate Cyclase: Allosteric Activation and Redox Regulation

  2010cites this paper
• The xanthine derivative KMUP‐1 inhibits models of pulmonary artery hypertension via increased NO and cGMP‐dependent inhibition of RhoA/Rho kinase

  2010cites this paper
• NO-independent activators of soluble guanylate cyclase: therapeutic potential.

  2009cites this paper
• NO-independent, haem-dependent soluble guanylate cyclase stimulators.

  2009cites this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cites this paper
• Therapeutic targets in pulmonary arterial hypertension.

  2009cites this paper
• Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.

  2009cites this paper
• Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.

  2009cites this paper
• NO signaling through cGMP in renal tissue fibrosis and beyond: key pathway and novel therapeutic target.

  2008cites this paper
• Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism.

  2008cites this paper
• Papel del óxido nítrico en la fisiologïa normal de la vía aérea y sus implicaciones en la fisiopatología de la hipertensión pulmonar

  2008cites this paper
• Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.

  2007cites this paper
• Recent Advances in the Pathogenesis and Treatment of Persistent Pulmonary Hypertension of the Newborn

  2007cites this paper
• Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.

  2007cites this paper
• Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside.

  2007cites this paper
• EFFECT OF BAY 41‐2272 IN THE PULMONARY HYPERTENSION INDUCED BY HEPARIN–PROTAMINE COMPLEX IN ANAESTHETIZED DOGS

  2007cites this paper
• Therapy of pulmonary hypertension in neonates and infants.

  2007cites this paper
• Update in pulmonary hypertension 2005.

  2006cites this paper
• NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

  2006cites this paper
• Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.

  2006cites this paper
• Molecular Mechanisms Underlying Rat Mesenteric Artery Vasorelaxation Induced by the Nitric Oxide-Independent Soluble Guanylyl Cyclase Stimulators BAY 41-2272 [5-Cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Inda

  2006cites this paper
• Molecular Mechanisms Underlying Rat Mesenteric Artery Vasorelaxation Induced by the Nitric Oxide-Independent Soluble Guanylyl Cyclase Stimulators BAY 41-2272 [5-Cyclopropyl-2-[1-(2-fluorobenzyl)-1 H -pyrazolo[3,4- b ]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5 (cid:1) -Hydroxymethyl-2 (cid:1) -

  2006cites this paper
• BAY 41-2272, a Direct Activator of Soluble Guanylate Cyclase, Reduces Right Ventricular Hypertrophy and Prevents Pulmonary Vascular Remodeling during Chronic Hypoxia in Neonatal Rats

  2006cites this paper
• BAY 41-2272 [5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-Induced Dilation in Ovine Pulmonary Artery: Role of Sodium Pump

  2005cites this paper
• Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.

  2005influential citation
• Aortic Smooth Muscle Relaxants KMUP-3 and KMUP-4, Two Nitrophenylpiperazine Derivatives of Xanthine, Display cGMP-Enhancing Activity: Roles of Endothelium, Phosphodiesterase, and K+ Channel

  2005cites this paper